<DOC>
	<DOCNO>NCT01149967</DOCNO>
	<brief_summary>This bioequivalence study Citalopram Hydrobromide Tablets 40 mg Dr.Reddy 's Laboratories Limited fasting condition .</brief_summary>
	<brief_title>Bioequivalence Study Citalopram Hydrobromide Tablets 40 mg Dr.Reddy 's Laboratories Limited Under Fasting Conditions</brief_title>
	<detailed_description>randomize , 2-way crossover ; bioequivalence study citalopram hydrobromide 40mg tablet celexa 40 mg tablet administer 1 x 40 mg tablet healthy subject fast condition</detailed_description>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>Subjects enrol study member community large . The recruitment advertisement may use various medium type ( e.g . radio , newspaper , Anapharm Inc.Web site , Anaphann Inc. volunteer ' data base ) . Subjects must meet follow criterion order include study : Nonchildbearing potential female male , smoker and/or nonsmoker , 18 year age old . Subjects capable consentW Nonchildbearing potential female subject : Postmenopausal state : absence menses 12 month prior drug administration hysterectomy bilateral oophorectomy least 6 month prior drug administration . Surgically sterile : hysterectomy , bilateral oophorectomy , tubal ligation least 6 month prior drug administration . Subjects follow applies exclude study : Clinically significant illness within 4 week prior administration study medication . Clinically significant surgery within 4 week prior administration study medication . Any clinically significant abnormality find medical screening . Any reason , opinion Medical SubInvestigator , would prevent subject participate study . Abnormal laboratory test judge clinically significant . Positive urine drug screen screen . Positive test hepatitis B , hepatitis C , Human Immunodeficiency Virus ( HIV ) screening . ECG abnormality ( clinically significant ) vital sign abnormality ( systolic blood pressure low 90 140 mmHg , diastolic blood pressure low 50 90 mmHg , heart rate less 50 100 bpm ) screening . Subjects Body Mass Index ( BMI ) 2:30.0 . History significant alcohol abuse within six month prior screen visit indication regular use fourteen unit alcohol per week ( 1 Unit = 150 mL wine , 360 mL beer , 45 mL 40 % alcohol ) . History drug abuse use illegal drug : use soft drug ( marijuana ) within 3 month prior screen visit hard drug ( cocaine , phencyclidine [ PCP ] crack ) within 1 year prior screen visit . History allergic reaction citalopram hydrobromide relate drug . History allergic reaction heparin . Use drug know induce inhibit hepatic drug metabolism ( examples inducer : barbiturate , carbamazepine , phenytoin , glucocorticoid , rifampin/rifabutin ; examples inhibitor : antidepressant , cimetidine , diltiazem , erythromycin , ketoconazole , Mono Amine Oxidase ( MAO ) inhibitor , neuroleptic , verapamil , quinidine ) within 30 day prior administration study medication . Use investigational drug participation investigational study within 30 day prior administration study medication . Clinically significant history presence clinically significant gastrointestinal pathology ( e.g . chronic diarrhea , inflammatory bowel disease ) . Unresolved gastrointestinal symptom ( e.g . diarrhea , vomit ) , liver kidney disease , condition know interfere absorption , distribution , metabolism , excretion drug . Any clinically significant history presence clinically significant neurological , endocrinal , cardiovascular , pulmonary , hematologic , immunologic , psychiatric metabolic disease . Use prescription medication ( include hormone therapy ) within 14 day prior administration study medication overthecounter product ( include natural food supplement , vitamin , garlic supplement ) within 7 day prior administration study medication , except topical product without systemic absorption . Smoking 25 cigarette per day . Any food allergy , intolerance , restriction special diet could , opinion Medical SubInvestigator , contraindicate subject 's participation study . A depot injection implant drug within 3 month prior administration study medication . Donation plasma ( 500 mL ) within 7 day prior drug administration . Donation loss whole blood prior administration study medication follow : less 300 mL whole blood within 30 day , 300 mL 500 mL whole blood within 45 day 500 mL whole blood within 56 day prior drug administration . Consumption food beverage contain grapefruit ( e.g . fresh , can . frozen ) within 7 day prior administration study medication . History seizure disorder bipolar affective disorder . Active psychiatric diagnosis .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>Bioequivalence</keyword>
	<keyword>Citalopram</keyword>
	<keyword>Crossover</keyword>
</DOC>